SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Microbot Medical Inc. (MBOT) (CIK 0000883975) (MBOT) — Apr 8, 2016

Microbot Medical Inc. (MBOT) (CIK 0000883975)
Date: April 8, 2016 · CIK: 0000883975 · Accession: 0000000000-16-071456

AI Filing Summary & Sentiment

File numbers found in text: 000-19871

Date
April 8, 2016
Author
/s/ Suzanne Hayes
Form
UPLOAD
Company
Microbot Medical Inc. (MBOT) (CIK 0000883975)

Letter

Mail Stop 4720 April 8, 2016 Dr. Ian Massey President and Chief Executive Office r StemCells, Inc. 7707 Gateway Blvd . Newark, CA 94560

Re: StemCells, Inc. Form PRE 14A Filed March 14, 2016 File No. 000-19871

Dear Dr. Massey :

We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy a nd adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Suzanne Hayes

Show Raw Text
Mail Stop 4720
April 8, 2016

Dr. Ian Massey
President and Chief Executive Office r
StemCells, Inc.
7707 Gateway Blvd .
Newark, CA 94560

Re: StemCells, Inc.
 Form PRE 14A
Filed March 14,  2016
File No. 000-19871

Dear Dr. Massey :

We have completed our review of your filing .  We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from taking
any action with respect to the company or the filing and the company may not assert staff
comments as a defense in any proceeding initiated by the Commission or any person under the
federal securities laws of the United States.  We urge all persons who are responsible for the
accuracy a nd adequacy of the disclosure in the filing to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Suzanne Hayes

Suzanne Hayes
Assistant Director
Office of Healthcare and Insurance